» Articles » PMID: 30006231

Detection of Mucopolysaccharidosis III-A (Sanfilippo Syndrome-A) in Dried Blood Spots (DBS) by Tandem Mass Spectrometry

Overview
Journal Mol Genet Metab
Specialty Endocrinology
Date 2018 Jul 15
PMID 30006231
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: With ongoing efforts to develop improved treatments for Sanfilippo Syndrome Type A (MPS-IIIA), a disease caused by the inability to degrade heparan sulfate in lysosomes, we sought to develop an enzymatic activity assay for the relevant enzyme, sulfamidase, that uses dried blood spots (DBS).

Methods: We designed and synthesized a new sulfamidase substrate that can be used to measure sulfamidase activity in DBS using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Results: Sulfamidase activity was readily detected in DBS using the new substrate and LC-MS/MS. Sulfamidase activity showed acceptable linearity proportional to the amount of enzyme and reaction time. Sulfamidase activity in 238 random newborns was well elevated compared to the range of activities measured in DBS from 8 patients previously confirmed to have MPS-IIIA.

Conclusions: This is the first report of an assay capable of detecting sulfamidase in DBS. The new assay could be useful in diagnosis and potentially for newborn screening of MPS-IIIA.

Citing Articles

Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses.

Li J, Mao S, Chao Y, Hu C, Qian Y, Dai Y Orphanet J Rare Dis. 2024; 19(1):179.

PMID: 38685110 PMC: 11059687. DOI: 10.1186/s13023-024-03195-w.


Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis.

Herbst Z, Hong X, Urdaneta L, Klein T, Waggoner C, Liao H Mol Genet Metab. 2023; 140(1-2):107632.

PMID: 37407323 PMC: 10748792. DOI: 10.1016/j.ymgme.2023.107632.


Liquid Chromatography-Tandem Mass Spectrometry in Newborn Screening Laboratories.

Gelb M, Basheeruddin K, Burlina A, Chen H, Chien Y, Dizikes G Int J Neonatal Screen. 2022; 8(4).

PMID: 36547379 PMC: 9781967. DOI: 10.3390/ijns8040062.


Sanfilippo syndrome: consensus guidelines for clinical care.

Muschol N, Giugliani R, Jones S, Muenzer J, Smith N, Whitley C Orphanet J Rare Dis. 2022; 17(1):391.

PMID: 36303195 PMC: 9612603. DOI: 10.1186/s13023-022-02484-6.


Tandem Mass Spectrometry Enzyme Assays for Multiplex Detection of 10-Mucopolysaccharidoses in Dried Blood Spots and Fibroblasts.

Khaledi H, Gelb M Anal Chem. 2020; 92(17):11721-11727.

PMID: 32786498 PMC: 8026088. DOI: 10.1021/acs.analchem.0c01750.


References
1.
Chennamaneni N, Kumar A, Barcenas M, Spacil Z, Scott C, Turecek F . Improved reagents for newborn screening of mucopolysaccharidosis types I, II, and VI by tandem mass spectrometry. Anal Chem. 2014; 86(9):4508-14. PMC: 4014144. DOI: 10.1021/ac5004135. View

2.
Hopwood J, Elliott H . Radiolabelled oligosaccharides as substrates for the estimation of sulfamidase and the detection of the Sanfilippo type A syndrome. Clin Chim Acta. 1981; 112(1):55-66. DOI: 10.1016/0009-8981(81)90268-0. View

3.
Spacil Z, Tatipaka H, Barcenas M, Scott C, Turecek F, Gelb M . High-throughput assay of 9 lysosomal enzymes for newborn screening. Clin Chem. 2013; 59(3):502-11. PMC: 4737435. DOI: 10.1373/clinchem.2012.189936. View

4.
Hopwood J, Elliott H . Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate. Clin Chim Acta. 1982; 123(3):241-50. DOI: 10.1016/0009-8981(82)90168-1. View

5.
Dulaney S, Xu Y, Wang P, Tiruchinapally G, Wang Z, Kathawa J . Divergent Synthesis of Heparan Sulfate Oligosaccharides. J Org Chem. 2015; 80(24):12265-79. PMC: 4685427. DOI: 10.1021/acs.joc.5b02172. View